Shenzhen Salubris Pharmaceuticals Co Ltd (002294) — Capital Reinvestment Ratio
Shenzhen Salubris Pharmaceuticals Co Ltd (002294) has a Capital Reinvestment Ratio of 0.73x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥400.70 Million) in capital expenditures (CN¥292.24 Million). See Shenzhen Salubris Pharmaceuticals Co Ltd balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shenzhen Salubris Pharmaceuticals Co Ltd Capital Reinvestment Ratio (2006–2024)
This chart tracks Shenzhen Salubris Pharmaceuticals Co Ltd's Capital Reinvestment Ratio across 19 annual periods. Check 002294 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shenzhen Salubris Pharmaceuticals Co Ltd (2006–2024)
Year-by-year Capital Reinvestment Ratio for Shenzhen Salubris Pharmaceuticals Co Ltd from 2006 to 2024. For live market cap and broader valuation context, see how much is Shenzhen Salubris Pharmaceuticals Co Ltd worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.53x | CN¥1.19 Billion | CN¥624.81 Million | ▼ -31.7% |
| 2023 | 0.77x | CN¥869.79 Million | CN¥671.00 Million | ▲ +25.0% |
| 2022 | 0.62x | CN¥970.80 Million | CN¥598.96 Million | ▲ +51.5% |
| 2021 | 0.41x | CN¥1.18 Billion | CN¥482.50 Million | ▼ -12.9% |
| 2020 | 0.47x | CN¥1.37 Billion | CN¥642.47 Million | ▲ +54.1% |
| 2019 | 0.30x | CN¥1.51 Billion | CN¥457.19 Million | ▲ +22.2% |
| 2018 | 0.25x | CN¥1.34 Billion | CN¥332.87 Million | ▲ +9.1% |
| 2017 | 0.23x | CN¥1.46 Billion | CN¥331.67 Million | ▲ +33.2% |
| 2016 | 0.17x | CN¥1.43 Billion | CN¥245.06 Million | ▼ -23.4% |
| 2015 | 0.22x | CN¥1.06 Billion | CN¥235.57 Million | ▲ +9.2% |
| 2014 | 0.20x | CN¥982.25 Million | CN¥200.65 Million | ▼ -68.0% |
| 2013 | 0.64x | CN¥668.52 Million | CN¥427.20 Million | ▲ +16.2% |
| 2012 | 0.55x | CN¥521.21 Million | CN¥286.75 Million | ▼ -40.7% |
| 2011 | 0.93x | CN¥272.32 Million | CN¥252.60 Million | ▼ -22.5% |
| 2010 | 1.20x | CN¥186.65 Million | CN¥223.48 Million | ▲ +18.5% |
| 2009 | 1.01x | CN¥134.28 Million | CN¥135.68 Million | ▲ +28.0% |
| 2008 | 0.79x | CN¥77.89 Million | CN¥61.48 Million | ▲ +203.8% |
| 2007 | 0.26x | CN¥52.75 Million | CN¥13.71 Million | ▼ -67.9% |
| 2006 | 0.81x | CN¥12.00 Million | CN¥9.71 Million | — |